Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC δ signal transduction

Oncogene

Volumn 23, Issue 10, 2004, Pages 1845-1853

  Woo, Ju Hyung ^a   Lim, Jun Hee ^a   Kim, Young Ho ^a   Suh, Seong Il ^a   Min, Do Sik ^b   Chang, Jong Soo ^c   Lee, Young Han ^d   Park, Jong Wook ^a   Kwon, Taeg Kyu ^a  

^a Keimyung University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Daejin University   (South Korea)

^d Yeungnam University College of Medicine   (South Korea)

Author keywords

JNK; Matrix metalloproteinase 9; Nf B; PKC; PMA; Resveratrol

Indexed keywords

CYTOKINE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOALEXIN; PROTEIN KINASE C DELTA; PROTEINASE; RESVERATROL; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL ASSAY; CELL INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA RESPONSIVE ELEMENT; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; EXTRACELLULAR MATRIX; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INACTIVATION; GENETIC TRANSFECTION; GRAPE; HUMAN; HUMAN CELL; METASTASIS; MOLECULAR CLONING; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BASE SEQUENCE; CELL LINE, TUMOR; CLONING, MOLECULAR; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NF-KAPPA B; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; PROTEIN KINASE C-DELTA; SIGNAL TRANSDUCTION; STILBENES; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

VITACEAE; VITIS SP.;

EID: 1842482424     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207307     Document Type: Article

References (30)

1. Baek WK, Park JW, Lim JH, Suh SI, Suh MH and Kwon TK. (2002). Gene, 295, 117-123.
2. Banerjee S, Bueso-Ramos C and Aggarwal BB. (2002). Cancer Res., 62, 4945-4954.
3. Bernhard EJ, Gruber SB and Muschel RJ. (1994). Proc. Natl. Acad. Sci. USA, 91, 4293-4297.
4. Brew K, Dinakarpandian D and Nagase H. (2000). Biochim. Biophys. Acta, 1477, 267-283.
5. Chambers AF and Matrisian LM. (1997). J. Natl. Cancer Inst., 89, 1260-1270.
6. Cirillo G, Casalino L, Vallone D, Caracciolo A, De Cesare D and Verde P. (1999). Mol. Cell. Biol., 19, 6240-6252.
7. Fauconneau B, Waffo-Teguo P, Huguet F, Barrier L, Decendit A and Merillon JM. (1997). Life Sci., 61, 2103-2110.
8. Fremont L. (2000). Life Sci., 66, 6663-6673.
9. Godichaud S, Krisa S, Couronne B, Dubuisson L, Merillon JM, Desmouliere A and Rosenbaum J. (2000). Hepatology, 31, 922-931.
10. Gum R, Wang H, Lengyel E, Juarez J and Boyd D. (1997). Oncogene, 14, 1481-1493.
11. Gupta S, Campbell D, Derijard B and Davis RJ. (1995). Science, 267, 389-393.
12. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Kleiner DE and Stetler-Stevenson WG. (1999). Cancer Chemother. Pharmacol., 43 (Suppl), S42-S51.
13. Lee PP, Hwang JJ, Murphy G and Ip MM. (2000). Endocrinology, 141, 3764-3773.
14. Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Davis RJ, Johnson GL and Karin M. (1994a). Science, 266, 1719-1723.
15. Minden A, Lin A, Smeal T, Derijard B, Cobb M, Davis R and Karin M. (1994b). Mol. Cell. Biol., 14, 6683-6688.
16. Nagase H and Woessner Jr JF. (1999). J. Biol. Chem., 274, 21491-21494.
17. O'Hagan RC, Tozer RG, Symons M, McCormick F and Hassell JA. (1996). Oncogene, 13, 1323-1333.
18. Overall CM, Wrana JL and Sodek J. (1989). J. Biol. Chem., 264, 1860-1869.
19. Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP and Goldberg DM. (1996). Clin. Chim. Acta, 246, 163-182.
20. Sato H, Kita M and Seiki M. (1993). J. Biol. Chem., 268, 23460-23468.
21. Sato H and Seiki M. (1993). Oncogene, 8, 395-405.
22. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M. (1994). Nature, 370, 61-65.
23. Simon C, Goepfert H and Boyd D. (1998). Cancer Res., 58, 1135-1139.
24. Soleas GJ, Diamandis EP and Goldberg DM. (1997a). J. Clin. Lab. Anal., 11, 287-313.
25. Soleas GJ, Diamandis EP and Goldberg DM. (1997b). Clin. Biochem., 30, 91-113.
26. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA and Goldberg GI. (1995). J. Biol. Chem., 270, 5331-5338.
27. Uddin S, Sassano A, Deb DK, Verma A, Majchrzak B, Rahman A, Malik AB, Fish EN and Platanias LC. (2002). J. Biol. Chem., 277, 14408-14416.
28. Waas ET, Lomme RM, DeGroot J, Wobbes T and Hendriks T. (2002). Br. J. Cancer, 86, 1876-1883.
29. Woodhouse EC, Chuaqui RF and Liotta LA. (1997). Cancer, 80, 1529-1537.
30. Zucker S, Lysik RM, Zarrabi MH and Moll U. (1993). Cancer Res., 53, 140-146.